0045sek
-0,4 %
Date:2025-06-26Time:16:19:23Latest report:Q1-2025List:First NorthTicker:GABA
Market Cap:11 msekEnterprise Value:6 msekNet Sales:- msekEarnings:-4,85 msekEmployees:0ISIN:SE0010869552

Ratios

10-year key figure history for Gabather turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Gabather with index and moving average MA50 and MA200.

Stockprice:0,045
MA50:0,04
MA200:0,30
Price/MA200:-84,9 %
RSI (14):48,6
Price/MA50:-0,1 %

Description

Gabather is a pharmaceutical company. Today, there is a business focus on developing drug candidates for the treatment of nerve diseases. Particular focus is on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are today patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.

Biotechnology